GlassScriptPhysician profile
Patrick William Daniel Moody
NPI 1528455243
$9,406.53
in general payments reported to CMS, 2019-2025
17 companies · $409 in 2025
The $409 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $1,214 · 2021: $6,138 · 2022: $149 · 2023: $896 · 2024: $287 · 2025: $409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $808 · Food and Beverage: $784.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $808.36 |
| Food and Beverage | $784.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Peerless Surgical INC. | $7,060.59 | 2020-2021 | |
| Stryker Corporation | $952.31 | 2023-2024 | Mako, 1788 |
| Depuy Synthes Sales INC. | $289.76 | 2021-2025 | |
| Ferring Pharmaceuticals INC. | $205.72 | 2023-2025 | Euflexxa |
| Medical Device Business Services, INC. | $174.99 | 2020 | |
| Smith+Nephew, INC. | $142.62 | 2022-2025 | Stravix |
| Zimmer Biomet Holdings, INC. | $116.65 | 2019 | |
| Bioventus LLC | $113.16 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $112.71 | 2025 | |
| Acumed LLC | $83.84 | 2019 | |
| Saluda Medical Americas, INC. | $27.06 | 2025 | Evoke |
| Ermi LLC | $26.25 | 2025 | |
| Boston Scientific Corporation | $22.32 | 2025 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $21.94 | 2023 | Senza |
| Smoky Mountain Surgical LLC | $19.94 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $18.43 | 2024 | Xiaflex |
| Solventum Corporation | $18.24 | 2024 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Moody listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.